July 12, 2017
Daiichi Sankyo said on July 11 that its oncolytic virus G47Δ (recombinant herpes virus; development code: DS-1647) has been granted orphan drug designation. The virus is being developed jointly with the University of Tokyo’s Institute of Medical Science. G47Δ is...read more